Kymera Therapeutics, Inc.

Q3 2025 13F Holders

Symbol
KYMR
CUSIP
501575104
Type
Equity
Class
COM
Num filings
220
Total reported value, excl. options
$4.59 B
Manager Report Date Value ($000) Shares Option Type